SCHEMBL3405665

SCHEMBL3405665

Cc1nc(N2CCCCC2)sc1C(=O)N1CCN(C(C)C)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.45
HPGD P15428 1/20 0.45
PIK3CD O00329 1/20 0.45
PIK3CA P42336 1/20 0.45
PIK3CB P42338 1/20 0.45
HRH3 Q9Y5N1 9/20 0.45
MAPK1 P28482 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
PKM P14618 1/20 0.43
HTR2C P28335 1/20 0.42
MAPT P10636 2/20 0.42
LMNA P02545 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
KDM4E B2RXH2 2/20 0.41
GAA P10253 2/20 0.41
CHRNA7 P36544 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3402654 0.81 SIGLEC9 (0.48) ALDH1A1HPGDHRH3MAPK1HTR2C
SCHEMBL17452584 0.76 PIK3CD (0.52) ALDH1A1HPGDPIK3CDPIK3CAPIK3CB
SCHEMBL16404868 0.76 PIK3CD (0.72) ALDH1A1HPGDPIK3CDPIK3CAPIK3CB
SCHEMBL13787617 0.74 PIK3CD (0.74) ALDH1A1HPGDPIK3CDPIK3CAPIK3CB
SCHEMBL8738721 0.74 PIK3CD (0.56) ALDH1A1PIK3CDPIK3CAPIK3CBMAPK1
Hydrochloric Acid SCHEMBL6113991 0.73 PIK3CD (0.55) ALDH1A1PIK3CDPIK3CAPIK3CBMAPK1
SCHEMBL3405399 0.72 CNR1 (0.57) ALDH1A1HRH3SMN1; SMN2HTR2CMAPT
SCHEMBL3401781 0.72 CNR1 (0.70) ALDH1A1HPGDHRH3SMN1; SMN2HTR2C
SCHEMBL3404912 0.72 CNR1 (0.51) HRH3SMN1; SMN2HTR2CKDM4EGAA
SCHEMBL20176403 0.72 ALDH1A1 (0.51) ALDH1A1HPGDPIK3CDPIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100297035-A1 Thiazole Amides, Imidazole Amides and Related Analogues LIGAND PHARMACEUTICALS, INC. (US) 2010-11-25 US disclosed
US-7728009-B1 Thiazole amides, imidazole amides and related analogues NEUROGEN CORPORATION (US) 2010-06-01 US disclosed
US-7728009-B1 Thiazole amides, imidazole amides and related analogues NEUROGEN CORPORATION (US) 2010-06-01 US disclosed
US-7728009-B1 Thiazole amides, imidazole amides and related analogues NEUROGEN CORPORATION (US) 2010-06-01 US disclosed
WO-2006089076-A9 THIAZOLE AMIDES, IMIDAZOLE AMIDES AND RELATED ANALOGUES NEUROGEN CORP (US) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297035-A1 Thiazole Amides, Imidazole Amides and Related Analogues HRH3, HRH4, HRH2 ALDH1A1 916/4885HPGD 1057/4885PIK3CD 3841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.